查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824301

2025年全球类器官市场报告

Organoids Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年类器官市场规模将呈指数级增长，到2029年将达到107.6亿美元，复合年增长率为22.2%。预测期内的成长可归因于慢性病盛行率的上升、基因组编辑技术的进步、干细胞研究的增加、合作研究与伙伴关係的加强以及临床转化工作。预测期内的主要趋势包括再生医学应用、体内成像技术、多器官系统合作研究、伦理和法律考虑、商业化以及市场扩张。

未来五年22.2%的成长率预测比我们先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。关税上涨可能会增加来自瑞典和日本的3D生物列印系统和干细胞培养基成分的成本，从而加剧药物开发成本，并延缓个人化医疗的突破，从而给美国生物医学研究带来压力。此外，关税上涨也将透过互惠关税以及贸易紧张局势和限制升级对全球经济和贸易的负面影响，更广泛地体现出来。

慢性病和感染疾病和盛行率不断上升，预计将推动未来类器官市场的成长。慢性病是一种持续时间超过一年并需要持续医疗照护的疾病。类器官正被用于研究各种慢性病及其治疗方法，为病原体生物学和药物筛检提供即时可靠的见解。因此，这些疾病的发生率和盛行率不断上升将加强类器官市场。例如，2024 年 6 月，英国公共医疗保健系统国家医疗服务体系 (NHS) 报告称，2023 年有 3,615,330 名在 GP 註册的个人被诊断出患有非糖尿病性高血糖症或糖尿病前期，比 2022 年的 3,065,825 人增加约 18%。因此，慢性病盛行率的不断上升预计将推动类器官市场的发展。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球类器官：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球类器官市场：成长率分析
  • 全球类器官市场表现：规模与成长，2019-2024
  • 全球类器官市场预测：规模与成长，2024-2029年，2034年
  • 全球类器官：总潜在市场（TAM）

第六章 市场细分

  • 全球类器官市场（依产品、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 肝臟类器官
  • 结肠和直肠类器官
  • 肠道类器官
  • 其他的
  • 全球类器官市场（依来源）：2019-2024 年、2024-2029 年、2034 年表现与预测
  • 多功能细胞
  • 器官特异性成体干细胞
  • 全球类器官市场的应用、表现与预测（2019-2024、2024-2029、2034）
  • 发育生物学
  • 感染疾病病理学
  • 再生医学
  • 药物毒性和疗效测试
  • 药物研发与个人化医疗
  • 其他的
  • 全球类器官市场（依最终使用者划分）：2019-2024 年、2024-2029 年、2034 年表现与预测
  • 医院和诊断中心
  • 生物技术和製药公司
  • 其他的
  • 全球类器官市场：肝臟类器官细分、类型、表现及预测（2019-2024、2024-2029、2034）
  • 肝干细胞衍生的类器官
  • 原代肝细胞衍生的类器官
  • 肝肿瘤类器官
  • 全球类器官市场：结直肠类器官细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 结肠类器官
  • 直肠类器官
  • 结肠类器官
  • 全球类器官市场：肠道类器官细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 小肠类器官
  • 肠热病类器官
  • 肠道干细胞衍生的类器官
  • 全球类器官市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 胰臟类器官
  • 脑类器官
  • 肾臟类器官
  • 肺类器官
  • 其他的

第七章 区域和国家分析

  • 全球类器官市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球类器官市场：国家、表现与预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 类器官市场：竞争格局
  • 类器官市场：公司简介
    • Cellesce Ltd.
    • STEMCELL Technologies
    • HUB Organoids
    • DefiniGEN
    • 3Dnamics Inc.

第31章：其他领先和创新企业

  • OcellO BV
  • Organoid Therapeutics
  • PeproTech Inc.
  • QGel SA
  • Corning Incorporated
  • Thermo Fisher Scientific
  • Trevigen Inc.
  • Path BioAnalytics
  • R&D Systems
  • Merck KGaA
  • 3D BioMatrix Inc.
  • 3D BIoTek LLC
  • AMS BIoTechnology（Europe）Limited
  • Greiner Bio-One
  • 3-D Matrix

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年类器官市场：提供新机会的国家
  • 2029年类器官市场：细分领域带来新机会
  • 2029年类器官市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24386u

Organoids, intricate three-dimensional tissue cultures derived from stem cells, serve as invaluable assets in tailored regenerative medicine, gene repair, and transplantation therapy.

These organoids come in various forms such as hepatic, colorectal, and intestinal, among others. Hepatic organoids, for instance, represent fully functional in vitro models of the liver. They play a pivotal role in addressing an array of research queries related to hepatic development, regeneration, and disease modeling. These groundbreaking tools harness different sources, including pluripotent stem cells and organ-specific adult stem cells. They find application across developmental biology, infectious disease pathology, regenerative medicine, drug efficacy and toxicity testing, as well as drug discovery and personalized medicine. Their adoption spans a wide spectrum, encompassing hospitals, diagnostic centers, biotechnology and pharmaceutical companies, and other industries seeking to leverage their immense potential for advancements in healthcare and research.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The organoids market research report is one of a series of new reports from The Business Research Company that provides organoids market statistics, including organoids industry global market size, regional shares, competitors with a organoids market share, detailed organoids market segments, market trends, and opportunities, and any further data you may need to thrive in the organoids industry. This organoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The organoids market size has grown exponentially in recent years. It will grow from $3.98 billion in 2024 to $4.82 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to biomedical research advances, drug discovery and development needs, disease modeling requirements, personalized medicine trends, and regulatory support.

The organoids market size is expected to see exponential growth in the next few years. It will grow to $10.76 billion in 2029 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to the increased prevalence of chronic diseases, advancements in genome editing techniques, rise in stem cell research, collaborations and partnerships, and clinical translation efforts. Major trends in the forecast period include application in regenerative medicine, in vivo imaging techniques, collaborations for multi-organoid systems, ethical and legal considerations, commercialization and market expansion.

The forecast of 22.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. biomedical research by driving up the cost of 3D bioprinting systems and stem cell culture media components sourced from Sweden and Japan, exacerbating drug development costs and delaying personalized medicine breakthroughs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

An increase in the incidence and prevalence of chronic and infectious diseases is expected to drive the growth of the organoid market in the future. Chronic diseases are conditions that persist for over a year and require continuous medical care. Organoids are utilized to investigate various chronic diseases and their treatments, as they provide immediate and reliable insights into pathogen biology and drug screening. Thus, the rise in the incidence and prevalence of these diseases will bolster the organoid market. For example, in June 2024, the National Health Service, a publicly funded healthcare system in the UK, reported that 3,615,330 individuals registered with a GP were diagnosed with non-diabetic hyperglycemia, or pre-diabetes, in 2023, up from 3,065,825 in 2022, representing an increase of nearly 18%. Therefore, the growing prevalence of chronic diseases is expected to propel the organoid market.

The escalating number of clinical trials aimed at drug development is set to fuel the expansion of the organoid market. These trials, totaling 452,604 globally as of May 17, 2023, registered on ClinicalTrials.gov-an increase from over 365,000 trials in early 2021, underscore the growing utilization of organoids. Leveraged in modeling diseases and refining personalized medicine, organoids play a pivotal role in advancing scientific understanding and improving patient care, solidifying their contribution to market growth.

Technological advancements stand as a prominent trend shaping the organoid market. Companies within this sector continuously introduce cutting-edge technologies to fortify their market positions. Notably, in March 2023, MIMETAS unveiled the OrganoReady product line featuring a novel adult stem cell-derived tubular organoid, harnessing innovative technology for mechanistic toxicology and drug-induced organ injury assessments. Developed on the patented microfluidic platform, OrganoPlate, these perfused 3D structures demonstrate the industry's commitment to pioneering advancements in organoid technologies.

Market leaders prioritize the development of pioneering platforms such as organoid panel screening, driving progress in preclinical oncology drug discovery. For example, in November 2023, Crown Bioscience launched OrganoidXplore, a revolutionary large-scale organoid panel screening platform. Utilizing their AR organoid technology, this platform streamlines preclinical drug discovery by offering reliable drug response comparisons that faithfully replicate original tumors' genomic, morphological, and pathophysiological characteristics. With enhanced performance and cost-effectiveness, OrganoidXplore signals a significant stride in accelerating oncology drug discovery.

In December 2022, Molecular Devices LLC, a UK-based research and development company, acquired Cellesce Ltd. for an undisclosed amount. The acquisition will provide Molecular Devices LLC with Cellesce Ltd human-derived cell or organoid lines and strengthen the company's position as a 3D biology solutions innovator. Cellesce Ltd is a UK-based company with expertise in cell expansion focused on organoids.

Major companies operating in the organoids market include Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, 3Dnamics Inc., OcellO B.V., Organoid Therapeutics, PeproTech Inc., QGel SA, Corning Incorporated, Thermo Fisher Scientific, Trevigen Inc., Path BioAnalytics, R&D Systems, Merck KGaA, 3D BioMatrix Inc., 3D Biotek LLC, AMS Biotechnology (Europe) Limited, Greiner Bio-One, 3-D Matrix, InSphero AG, Synthego Corporation, Axol Bioscience Ltd., TissUse GmbH, CytoSMART Technologies BV, EMD Millipore Corporation, Epithelix Sarl

North America was the largest region in the organoids market in 2024. Asia-pacific is expected to be the fastest-growing region in the global organoids market size forecast period. The regions covered in the organoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the organoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The organoids market consists of sales of epithelial organoid, embryonic organoid, and cerebral organoid. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Organoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The organoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Hepatic Organoid; Colorectal Organoid; Intestinal Organoid; Other Organoid
  • 2) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
  • 3) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
  • 4) By End-User: Hospitals And Diagnostic Centers; Biotechnology And Pharmaceutical Companies; Other End-Users
  • Subsegments:
  • 1) By Hepatic Organoid: Hepatic Stem Cell-Derived Organoids; Primary Liver Cell-Derived Organoids; Liver Tumor Organoids
  • 2) By Colorectal Organoid: Colonic Organoids; Rectal Organoids; Colorectal Cancer Organoids
  • 3) By Intestinal Organoid: Small Intestinal Organoids; Enteroid Organoids; Intestinal Stem Cell-Derived Organoids
  • 4) By Other Organoid: Pancreatic Organoids; Brain Organoids; Kidney Organoids; Lung Organoids; Others
  • Companies Mentioned: Cellesce Ltd.; STEMCELL Technologies; HUB Organoids; DefiniGEN; 3Dnamics Inc.; OcellO B.V.; Organoid Therapeutics; PeproTech Inc.; QGel SA; Corning Incorporated; Thermo Fisher Scientific; Trevigen Inc.; Path BioAnalytics; R&D Systems; Merck KGaA; 3D BioMatrix Inc.; 3D Biotek LLC; AMS Biotechnology (Europe) Limited; Greiner Bio-One; 3-D Matrix; InSphero AG; Synthego Corporation; Axol Bioscience Ltd.; TissUse GmbH; CytoSMART Technologies BV; EMD Millipore Corporation; Epithelix Sarl
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Organoids Market Characteristics

3. Organoids Market Trends And Strategies

4. Organoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Organoids Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Organoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Organoids Market Growth Rate Analysis
  • 5.4. Global Organoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Organoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Organoids Total Addressable Market (TAM)

6. Organoids Market Segmentation

  • 6.1. Global Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatic Organoid
  • Colorectal Organoid
  • Intestinal Organoid
  • Other Organoid
  • 6.2. Global Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pluripotent Stem Cells
  • Organ-Specific Adult Stem Cells
  • 6.3. Global Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Developmental Biology
  • Disease Pathology Of Infectious Disease
  • Regenerative Medicine
  • Drug Toxicity And Efficacy Testing
  • Drug Discovery And Personalized Medicine
  • Other Applications
  • 6.4. Global Organoids Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Centers
  • Biotechnology And Pharmaceutical Companies
  • Other End-Users
  • 6.5. Global Organoids Market, Sub-Segmentation Of Hepatic Organoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatic Stem Cell-Derived Organoids
  • Primary Liver Cell-Derived Organoids
  • Liver Tumor Organoids
  • 6.6. Global Organoids Market, Sub-Segmentation Of Colorectal Organoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Colonic Organoids
  • Rectal Organoids
  • Colorectal Cancer Organoids
  • 6.7. Global Organoids Market, Sub-Segmentation Of Intestinal Organoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Intestinal Organoids
  • Enteroid Organoids
  • Intestinal Stem Cell-Derived Organoids
  • 6.8. Global Organoids Market, Sub-Segmentation Of Other Organoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pancreatic Organoids
  • Brain Organoids
  • Kidney Organoids
  • Lung Organoids
  • Others

7. Organoids Market Regional And Country Analysis

  • 7.1. Global Organoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Organoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Organoids Market

  • 8.1. Asia-Pacific Organoids Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Organoids Market

  • 9.1. China Organoids Market Overview
  • 9.2. China Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Organoids Market

  • 10.1. India Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Organoids Market

  • 11.1. Japan Organoids Market Overview
  • 11.2. Japan Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Organoids Market

  • 12.1. Australia Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Organoids Market

  • 13.1. Indonesia Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Organoids Market

  • 14.1. South Korea Organoids Market Overview
  • 14.2. South Korea Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Organoids Market

  • 15.1. Western Europe Organoids Market Overview
  • 15.2. Western Europe Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Organoids Market

  • 16.1. UK Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Organoids Market

  • 17.1. Germany Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Organoids Market

  • 18.1. France Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Organoids Market

  • 19.1. Italy Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Organoids Market

  • 20.1. Spain Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Organoids Market

  • 21.1. Eastern Europe Organoids Market Overview
  • 21.2. Eastern Europe Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Organoids Market

  • 22.1. Russia Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Organoids Market

  • 23.1. North America Organoids Market Overview
  • 23.2. North America Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Organoids Market

  • 24.1. USA Organoids Market Overview
  • 24.2. USA Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Organoids Market

  • 25.1. Canada Organoids Market Overview
  • 25.2. Canada Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Organoids Market

  • 26.1. South America Organoids Market Overview
  • 26.2. South America Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Organoids Market

  • 27.1. Brazil Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Organoids Market

  • 28.1. Middle East Organoids Market Overview
  • 28.2. Middle East Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Organoids Market

  • 29.1. Africa Organoids Market Overview
  • 29.2. Africa Organoids Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Organoids Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Organoids Market Competitive Landscape And Company Profiles

  • 30.1. Organoids Market Competitive Landscape
  • 30.2. Organoids Market Company Profiles
    • 30.2.1. Cellesce Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. STEMCELL Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. HUB Organoids Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. DefiniGEN Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. 3Dnamics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Organoids Market Other Major And Innovative Companies

  • 31.1. OcellO B.V.
  • 31.2. Organoid Therapeutics
  • 31.3. PeproTech Inc.
  • 31.4. QGel SA
  • 31.5. Corning Incorporated
  • 31.6. Thermo Fisher Scientific
  • 31.7. Trevigen Inc.
  • 31.8. Path BioAnalytics
  • 31.9. R&D Systems
  • 31.10. Merck KGaA
  • 31.11. 3D BioMatrix Inc.
  • 31.12. 3D Biotek LLC
  • 31.13. AMS Biotechnology (Europe) Limited
  • 31.14. Greiner Bio-One
  • 31.15. 3-D Matrix

32. Global Organoids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Organoids Market

34. Recent Developments In The Organoids Market

35. Organoids Market High Potential Countries, Segments and Strategies

  • 35.1 Organoids Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Organoids Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Organoids Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer